Archive: 2026/02 - Page 2

Dong Quai and Warfarin: What You Need to Know About the Bleeding Risk

Dong Quai and Warfarin: What You Need to Know About the Bleeding Risk

Dong Quai and Warfarin can dangerously increase bleeding risk. Learn how this supplement-medication interaction works, evidence from experts, and steps to stay safe.

Read More
FDA Authorization of Generics: Legal Basis and Approval Process

FDA Authorization of Generics: Legal Basis and Approval Process

Learn how the FDA approves generic drugs under the Hatch-Waxman Act, including the ANDA process, bioequivalence requirements, patent challenges, and how this system keeps prescription costs low for millions of Americans.

Read More
The Purple Book: Understanding Biosimilars and Interchangeability from the FDA

The Purple Book: Understanding Biosimilars and Interchangeability from the FDA

The FDA's Purple Book is the official database for biological products, biosimilars, and interchangeable drugs. Learn how it works, what interchangeability means, and why it matters for patients and pharmacists.

Read More
TIA vs. Stroke: Warning Signs and Urgent Evaluation

TIA vs. Stroke: Warning Signs and Urgent Evaluation

A TIA is not a minor event-it's a critical warning that a stroke could happen within hours. Learn the real signs, why immediate action saves lives, and what happens after symptoms disappear.

Read More